NovaBridge Biosciences
NBP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001778016
In the last 90 days, NovaBridge Biosciences insiders filed 0 open-market purchases and 4 sales; 49 institutions reported holding it in 13F filings for Q2 2026, worth $48.1M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
13F holders, Q1 2022
Institutional positions in NovaBridge Biosciences as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 120
- −11 vs. Q4 2021
- Shares held
- 40.3M
- +1.28M (+3.3%) vs. Q4 2021
- Total value
- $654.5M
- −$1.20B (−64.6%) vs. Q4 2021
- New holders
- 17
- 58 more added
- Sold out
- 28
- 22 more reduced
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NBP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 49 | $48.1M |
| Q1 2026 | 48 | $72.1M |
| Q4 2025 | 57 | $132.1M |
| Q3 2025 | 42 | $112.3M |
| Q2 2025 | 32 | $22.7M |
| Q1 2025 | 29 | $7.41M |
| Q4 2024 | 28 | $10.1M |
| Q3 2024 | 28 | $17.6M |
| Q2 2024 | 38 | $25.3M |
| Q1 2024 | 39 | $22.7M |
| Q4 2023 | 44 | $23.5M |
| Q3 2023 | 47 | $20.1M |
| Q2 2023 | 48 | $55.9M |
| Q1 2023 | 53 | $71.6M |
| Q4 2022 | 69 | $103.9M |
| Q3 2022 | 75 | $123.3M |
| Q2 2022 | 97 | $430.3M |
| Q1 2022 | 120 | $654.5M |
| Q4 2021 | 132 | $1.85B |
| Q3 2021 | 145 | $2.61B |
| Q2 2021 | 136 | $2.38B |
| Q1 2021 | 80 | $1.13B |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding NovaBridge Biosciences; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Temasek Holdings (Private) Ltd | 566,650 | $9.20M | 0.04% | 00.0% | Unchanged |
| IvyRock Asset Management (HK) Ltd | 613,356 | $9.96M | 7.20% | +613,356 | New |
| Canada Pension Plan Investment Board | 617,000 | $10.0M | 0.01% | +146,000+31.0% | Added |
| Healthcare of Ontario Pension Plan Trust Fund | 678,600 | $11.0M | 0.04% | +361,700+114.1% | Added |
| Goldman Sachs Group Inc | 726,692 | $11.8M | 0.00% | +360,273+98.3% | Added |
| Assenagon Asset Management S.A. | 747,127 | $12.1M | 0.04% | +405,497+118.7% | Added |
| State Street Corp | 751,254 | $12.2M | 0.00% | +127,890+20.5% | Added |
| Artal Group S.A. | 850,000 | $13.8M | 0.58% | 00.0% | Unchanged |
| Bank of America Corp | 875,229 | $14.2M | 0.00% | +107,996+14.1% | Added |
| Vanguard Group Inc | 1,004,609 | $16.3M | 0.00% | +29,729+3.0% | Added |
| Octagon Capital Advisors LP | 1,049,691 | $17.0M | 3.69% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 1,400,000 | $22.7M | 0.04% | 00.0% | Unchanged |
| Artisan Partners Limited Partnership | 1,420,225 | $23.1M | 0.03% | +1,016,180+251.5% | Added |
| Morgan Stanley | 1,624,408 | $26.4M | 0.00% | +166,052+11.4% | Added |
| Cederberg Capital Ltd | 2,215,385 | $36.0M | 9.00% | −105,885−4.6% | Reduced |
| BlackRock Inc. | 3,403,271 | $55.3M | 0.00% | +938,531+38.1% | Added |
| Price T Rowe Associates Inc | 5,395,157 | $87.6M | 0.01% | −1,953,615−26.6% | Reduced |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 7,182,850 | $116.6M | 2.44% | 00.0% | Unchanged |
| DekaBank Deutsche Girozentrale | 3,250 | – | – | −19,371−85.6% | Reduced |
| International Biotechnology Trust PLC | 18,000 | – | – | 00.0% | Unchanged |
| National Bank of Canada | 0 | $0 | 0.00% | −289,300−100.0% | Sold out |
| Bellevue Group AG | 0 | $0 | 0.00% | −144,957−100.0% | Sold out |
| Quaero Capital S.A. | 0 | $0 | 0.00% | −76,159−100.0% | Sold out |
| Strategic Vision Investment Ltd | 0 | $0 | 0.00% | −61,800−100.0% | Sold out |
| Discovery Capital Management, LLC | 0 | $0 | 0.00% | −46,200−100.0% | Sold out |
| Perseverance Asset Management International | 0 | $0 | 0.00% | −36,678−100.0% | Sold out |
| Springs Capital (Hong Kong) Ltd | 0 | $0 | 0.00% | −35,184−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −29,130−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −16,900−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −12,859−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −12,820−100.0% | Sold out |
| New Silk Road Investment Pte Ltd | 0 | $0 | 0.00% | −12,000−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −10,745−100.0% | Sold out |
| Alliancebernstein L.P. | 0 | $0 | 0.00% | −8,916−100.0% | Sold out |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −7,859−100.0% | Sold out |
| Caisse de Depot Et Placement du Quebec | 0 | $0 | 0.00% | −6,800−100.0% | Sold out |
| Twinbeech Capital LP | 0 | $0 | 0.00% | −6,645−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −6,553−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −6,143−100.0% | Sold out |
| APG Asset Management N.V. | 0 | $0 | 0.00% | −5,069−100.0% | Sold out |
| Standard Life Aberdeen plc | 0 | $0 | 0.00% | −4,381−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −4,230−100.0% | Sold out |
| Eaton Vance Management | 0 | $0 | 0.00% | −240−100.0% | Sold out |
| Bank Julius Baer & Co. Ltd, Zurich | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −69−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −75−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −27−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Andra AP-fonden | – | – | – | – | Not filed |